Evidence map›Paper›PMID 40416946›Full record

ArticleClinical, cosmetic and investigational dermatology2025

Recovery Effects of Oral Supplementation with Polar Lipid-Rich Wheat Extracts on Acute Telogen Effluvium: A Randomized Double-Blind Placebo-Controlled Study.

Vincenzo Nobile, Stéphanie Dudonné, Catherine Kern, Enza Cestone, Christine Garcia

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vincenzo NobileR&D Department, Complife Italia S.r.l., San Martino Siccomario, Italy.ORCID 0000-0001-9147-302X
Stéphanie DudonnéResearch and Innovation Department, Seppic, La Garenne Colombes, France.ORCID 0000-0001-6581-4070
Catherine KernResearch and Innovation Department, Seppic, La Garenne Colombes, France.ORCID 0009-0003-2028-360X
Enza CestoneClinical Trial Department, Complife Italia S.r.l., San Martino Siccomario, Italy.
Christine GarciaResearch and Innovation Department, Seppic, La Garenne Colombes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute telogen effluvium (aTE) is a transient condition characterized by an early entry of the hair into the telogen phase. Purpose: This clinical study aimed at demonstrating the efficacy of a standardized wheat polar lipid complex both in oil (WPLC-O) and in powder (WPLC-P) form in improving hair shedding. Subjects and Methods: The study was carried out in 99 healthy women with aTE. Hair growth cycle related parameters (anagen/telogen hair), hair pull test, hair shaft mechanical properties (hair elongation at break) and hair growth were assessed at baseline and after 56 (D56) and/or 84 (D84) days of products use. These parameters were completed by the subject's self-assessment. Results: Telogen hair density was decreased by up to 26.9% and 24.2% while anagen density was increased by up to 10.3% and 10.8%, for WPLC-O and WPLC-P, respectively. These effects were significant compared with the placebo as early as within 56 days. These variations corresponded to an increase in the anagen/telogen ratio by up to 62.2% and 53.3% for WPLC-O and WPLC-P, respectively. Hair growth was also significantly increased in both active groups. At the end of the study the pull test was negative for aTE, exclusively in active treatment arms. Conclusion: Our findings demonstrated the efficacy of WPLC in both form in reducing hair shedding and in improving hair growth in women with aTE.

Indexed as

acute telogen effluviumdigalactosyl diglycerideshair sheddingnutricosmeticssphingolipids

Identifiers

PMID40416946
PMCPMC12103197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.